C5AR1 Antikörper (PE)
(3 Referenzen)Kurzübersicht für C5AR1 Antikörper (PE) (ABIN2472751)
Target
Alle C5AR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG conjugated to R. Phycoerythrin (RPE)
-
Isotyp
- IgG2b
-
-
anti-Complement Component 5a Receptor 1 (C5AR1) (C-Term) antibody
Verified C5AR1 Reaktivität: Human WB, FACS, ELISA, IHC, IF Wirt: Ziege Polyclonal unconjugated
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 15-27) antibodyC5AR1 Reaktivität: Human, Rind (Kuh), Kaninchen, Frettchen WB, FACS, IHC (p), IP Wirt: Maus Monoclonal S5-1 unconjugated
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 1-350) antibodyC5AR1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 4E2 unconjugated
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 1-36) antibodyC5AR1 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 15-27) antibody (FITC)C5AR1 Reaktivität: Human, Rind (Kuh), Kaninchen, Frettchen FACS Wirt: Maus Monoclonal S5-1 FITC
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 15-27) antibody (PE)C5AR1 Reaktivität: Human, Rind (Kuh), Kaninchen, Frettchen FACS Wirt: Maus Monoclonal S5-1 PE
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 15-27) antibody (APC)C5AR1 Reaktivität: Human, Rind (Kuh), Kaninchen, Frettchen FACS Wirt: Maus Monoclonal S5-1 APC
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 175-201) antibodyC5AR1 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB24276 unconjugated
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 1-350) antibodyC5AR1 Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 5a Receptor 1 (C5AR1) (AA 1-350) antibodyC5AR1 Reaktivität: Human WB, FACS Wirt: Maus Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
-
-
: "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 2, pp. 783-9, (2005) (PubMed).
: "C5a initiates the inflammatory cascade in immune complex peritonitis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 173, Issue 5, pp. 3437-45, (2004) (PubMed).
: "Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody." in: Immunology letters, Vol. 88, Issue 1, pp. 47-52, (2003) (PubMed).
-
: "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 2, pp. 783-9, (2005) (PubMed).
-
- C5AR1 (Complement Component 5a Receptor 1 (C5AR1))
-
Andere Bezeichnung
- CD88
-
Hintergrund
- Synonyms: C5aR
-
Gen-ID
- 12273
-
UniProt
- P30993
-
Pathways
- Komplementsystem
Target
-
